UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

Journal of bone and mineral research, 2017-09, Vol.32 (9), p.1945-1955

2017

Volltextzugriff (PDF)

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1198-1209

2016

Volltextzugriff (PDF)

The epidemiology and clinical correlates of HIV‐1 co‐receptor tropism in non‐subtype B infections from India, Uganda and South Africa

Journal of the International AIDS Society, 2012-01, Vol.15 (1), p.2-2

2012

Volltextzugriff (PDF)

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

BMC infectious diseases, 2021-02, Vol.21 (1), p.205-10, Article 205

2021

Volltextzugriff (PDF)

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

The New England journal of medicine, 2016-09, Vol.375 (9), p.830-839

2016

Volltextzugriff (PDF)

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

The New England journal of medicine, 2023-08, Vol.389 (8), p.687-699

2023

Volltextzugriff (PDF)

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

The New England journal of medicine, 2019-03, Vol.380 (11), p.1001-1011

2019

Volltextzugriff (PDF)

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet (British edition), 2022-03, Vol.399 (10330), p.1141-1153

2022

Volltextzugriff (PDF)

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

The New England journal of medicine, 2011-08, Vol.365 (6), p.493-505

2011

Volltextzugriff (PDF)

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

The Lancet (British edition), 2010-07, Vol.376 (9734), p.33-40

2010

Volltextzugriff (PDF)

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

The Journal of infectious diseases, 2020-07, Vol.222 (Supplement_1), p.S8-S19

2020

Volltextzugriff (PDF)

Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors

Clinical infectious diseases, 2012-09, Vol.55 (5), p.737-745

2012

Volltextzugriff (PDF)

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

Clinical infectious diseases, 2022-11, Vol.75 (10), p.1781-1791

2022

Volltextzugriff (PDF)

Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial

HIV medicine, 2015-04, Vol.16 (S1), p.1-9

2015

Volltextzugriff (PDF)

Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial

The Journal of infectious diseases, 2020-07, Vol.222 (Supplement_1), p.S20-S30

2020

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency

Clinical infectious diseases, 2020-07, Vol.71 (3), p.517-524

2020

Volltextzugriff (PDF)

Similar safety and efficacy of once- and twice-daily lopinavir/ritonavir tablets in treatment-experienced HIV-1-infected subjects at 48 weeks

Journal of acquired immune deficiency syndromes (1999), 2010-06, Vol.54 (2), p.143-151

2010

Volltextzugriff (PDF)

Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial

Clinical nutrition (Edinburgh, Scotland), 2019-06, Vol.38 (3), p.1303-1309

2019

Volltextzugriff (PDF)

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052

Journal of acquired immune deficiency syndromes (1999), 2017-12, Vol.76 (4), p.388-393

2017

Volltextzugriff (PDF)

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

Journal of acquired immune deficiency syndromes (1999), 2018-04, Vol.77 (5), p.484-491

2018

Volltextzugriff (PDF)

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study

Journal of acquired immune deficiency syndromes (1999), 2015-10, Vol.70 (2), p.163-171

2015

Volltextzugriff (PDF)

Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial

EClinicalMedicine, 2023-06, Vol.60, p.102030-102030, Article 102030

2023

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaHiv

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

The epidemiology and clinical correlates of HIV‐1 co‐receptor tropism in non‐subtype B infections from India, Uganda and South Africa

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial

Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial

Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial

Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

Similar safety and efficacy of once- and twice-daily lopinavir/ritonavir tablets in treatment-experienced HIV-1-infected subjects at 48 weeks

Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial

Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trialResearch in context

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study

Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trial

Aktive Filter

Suchergebnisse filtern